Patent details

301185 Product Name: Combinatie van daunorubicine en cytarabine

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301185
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP3300601
Status:
SPC granted but not yet in force
Application number:
301185
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/18/1308
Marketing Authorization Type:
EEA
Marketing Authorization Date:
27/08/2018
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
05/07/2022
First Marketing Authorization date:
27/08/2018
Grant date:
21/07/2022
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
06/07/2022
SPC/SPC Extension Expiration Date:
14/02/2033
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
05/07/2022
 
 

 

Name:
Rotalec IP Holdings LLC
Address:
3170 Porter Drive, Palo Alto, CA 94304, United States of America (US)

Agent

1

Name:
ir. B.Ch. Ledeboer c.s
From:
28/07/2025
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:

2

Name:
ir. H.A. Witmans c.s.
From:
05/07/2022
Address:
V.O. Postbus 87930, 2508 DH, Den Haag, Netherlands (NL)
To:
28/07/2025

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
30/22
Publication date:
27/07/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
27/22
Publication date:
06/07/2022
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
29/02/2028
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
21/07/2022 Outgoing Correspondence Decision grant 1 PDF /3/0/8/5/0/0800805803/docs/301185_7_494677l504a.pdf
21/07/2022 Certificate Certificate 1 PDF /3/0/8/5/0/0800805803/docs/301185_8_spcmedcertificate20220721125828811.pdf
06/07/2022 Outgoing Correspondence Confirmation receipt request 1 PDF /3/0/8/5/0/0800805803/docs/301185_0_491382l174.pdf
05/07/2022 Application Form First filed application form 3 PDF /3/0/8/5/0/0800805803/docs/301185_1_applicationform20220706095746009.pdf
05/07/2022 SPC Documents Marketing Authorization SPC 3 PDF /3/0/8/5/0/0800805803/docs/301185_2_supplprotectioncertificate20220706095746072.pdf
05/07/2022 SPC Documents Summary of the characteristics of the product 18 PDF /3/0/8/5/0/0800805803/docs/301185_3_supplprotectioncertificate20220706095746093.pdf
05/07/2022 SPC Documents Annex SPC 2 PDF /3/0/8/5/0/0800805803/docs/301185_4_supplprotectioncertificate20220706095746115.pdf
05/07/2022 SPC Documents Annex SPC 13 PDF /3/0/8/5/0/0800805803/docs/301185_5_supplprotectioncertificate20220706095746150.pdf
05/07/2022 SPC Documents Accompanying letter SPC 1 PDF /3/0/8/5/0/0800805803/docs/301185_6_supplprotectioncertificate20220706095746052.pdf